Your browser doesn't support javascript.
loading
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.
Sliepen, Kwinten; Schermer, Edith; Bontjer, Ilja; Burger, Judith A; Lévai, Réka Felfödiné; Mundsperger, Philipp; Brouwer, Philip J M; Tolazzi, Monica; Farsang, Attila; Katinger, Dietmar; Moore, John P; Scarlatti, Gabriella; Shattock, Robin J; Sattentau, Quentin J; Sanders, Rogier W.
Affiliation
  • Sliepen K; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Schermer E; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bontjer I; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Burger JA; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Lévai RF; Control Laboratory of Veterinary Medicinal Products and Animal Facility, Directorate of Veterinary Medicinal Products, National Food Chain Safety Office, Budapest, Hungary.
  • Mundsperger P; Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria.
  • Brouwer PJM; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Tolazzi M; Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Farsang A; Control Laboratory of Veterinary Medicinal Products and Animal Facility, Directorate of Veterinary Medicinal Products, National Food Chain Safety Office, Budapest, Hungary.
  • Katinger D; Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria.
  • Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Scarlatti G; Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Shattock RJ; Imperial College London, Department of Medicine, Division of Infectious Diseases, Section of Virology, Norfolk Place, London, W21PG, UK.
  • Sattentau QJ; The Sir William Dunn School of Pathology, The University of Oxford, Oxford, OX13RE, UK.
  • Sanders RW; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. r.w.sanders@amsterdamumc.nl.
NPJ Vaccines ; 6(1): 103, 2021 Aug 17.
Article in En | MEDLINE | ID: mdl-34404812
ABSTRACT
The immunogenicity of HIV-1 envelope (Env) trimers is generally poor. We used the clinically relevant ConM SOSIP trimer to compare the ability of different adjuvants (squalene emulsion, ISCOMATRIX, GLA-LSQ, and MPLA liposomes) to support neutralizing antibody (NAb) responses in rabbits. The trimers were administered as free proteins or on nanoparticles. The rank order for the adjuvants was ISCOMATRIX > SE > GLA-LSQ ~ MPLA liposomes > no adjuvant. Stronger NAb responses were elicited when the ConM SOSIP trimers were presented on ferritin nanoparticles. We also found that the GLA-LSQ adjuvant induced an unexpectedly strong antibody response to the ferritin core of the nanoparticles. This "off-target" effect may have compromised its ability to induce the more desired antitrimer antibodies. In summary, both adjuvants and nanoparticle display can improve the magnitude of the antibody response to SOSIP trimers but the best combination of trimer presentation and adjuvant can only be identified experimentally.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2021 Document type: Article Affiliation country: